DOMEBORO Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Domeboro, and what generic alternatives are available?
Domeboro is a drug marketed by Bayer Pharms and is included in one NDA.
The generic ingredient in DOMEBORO is acetic acid, glacial; aluminum acetate. There is one drug master file entry for this compound. Additional details are available on the acetic acid, glacial; aluminum acetate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DOMEBORO?
- What are the global sales for DOMEBORO?
- What is Average Wholesale Price for DOMEBORO?
Summary for DOMEBORO
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 21 |
| Patent Applications: | 4,106 |
| DailyMed Link: | DOMEBORO at DailyMed |
US Patents and Regulatory Information for DOMEBORO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Pharms | DOMEBORO | acetic acid, glacial; aluminum acetate | SOLUTION/DROPS;OTIC | 084476-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
